These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3624325)

  • 1. Pilot projects to stimulate adverse drug reaction reporting.
    Fincham JE
    J Clin Pharm Ther; 1987 Aug; 12(4):243-7. PubMed ID: 3624325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The yellow card: mark II.
    Lawson DH
    BMJ; 1990 Dec; 301(6763):1234. PubMed ID: 2271823
    [No Abstract]   [Full Text] [Related]  

  • 3. A drug information-ADR collection network: the French system.
    Dangoumau J; Lagier G; Royer RJ
    Drug Inf J; 1986; 20(3):337-46. PubMed ID: 10317774
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug recalls and notification of practitioners.
    Rodts MF
    Orthop Nurs; 2004; 23(6):353-4. PubMed ID: 15682877
    [No Abstract]   [Full Text] [Related]  

  • 5. Spontaneous reporting of adverse drug reactions. II: Uses.
    Rawlins MD
    Br J Clin Pharmacol; 1988 Jul; 26(1):7-11. PubMed ID: 3203063
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-safety pilot makes the grade.
    Ledford H
    Nature; 2014 Sep; 513(7519):472. PubMed ID: 25254456
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse drug reactions.
    Shuttleworth A
    Nurs Times; 2006 Jul 25-31; 102(30):58. PubMed ID: 16903313
    [No Abstract]   [Full Text] [Related]  

  • 8. Adverse drug reaction processing in the United States and its dependence on physician reporting: zomepirac (Zomax) as a case in point.
    Corre KA; Spielberg TE
    Ann Emerg Med; 1988 Feb; 17(2):145-9. PubMed ID: 3257365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Under FDA scrutiny: 19 drugs monitored for safety concerns].
    Sabourin G
    Perspect Infirm; 2010; 7(2):44-5. PubMed ID: 21744604
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse drug reaction reporting systems: the United Kingdom and the United States.
    Scott HD; Thacher A; Rosenbaum SE; Waters WJ; Green M
    R I Med J (1976); 1988 May; 71(5):179-84. PubMed ID: 3387803
    [No Abstract]   [Full Text] [Related]  

  • 11. A golden opportunity.
    Weary PE
    J Am Acad Dermatol; 1980 Dec; 3(6):647-8. PubMed ID: 7204683
    [No Abstract]   [Full Text] [Related]  

  • 12. The detection of adverse reactions to therapeutic drugs.
    Finney DJ
    Stat Med; 1982; 1(2):153-61. PubMed ID: 7187090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential surveillance for drug safety in a regulatory environment.
    Martin D; Gagne JJ; Gruber S; Izem R; Nelson JC; Nguyen MD; Ouellet-Hellstrom R; Schneeweiss S; Toh S; Walker AM
    Pharmacoepidemiol Drug Saf; 2018 Jul; 27(7):707-712. PubMed ID: 29504168
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of postmarketing surveillance in contemporary medicine.
    Woodcock J; Behrman RE; Dal Pan GJ
    Annu Rev Med; 2011; 62():1-10. PubMed ID: 20809798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reporting drug side effects: signals and noise.
    Avorn J
    JAMA; 1990 Apr; 263(13):1823. PubMed ID: 2313853
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA turns to electronic "sentinel" to flag prescription drug safety problems.
    Kuehn BM
    JAMA; 2008 Jul; 300(2):156-7. PubMed ID: 18612108
    [No Abstract]   [Full Text] [Related]  

  • 17. Adverse drug reaction monitoring: doing it the French way.
    Moore N; Biour M; Paux G; Loupi E; Begaud B; Boismare F; Royer RJ
    Lancet; 1985 Nov; 2(8463):1056-8. PubMed ID: 2865527
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse drug events and near misses: who's counting?
    Wu AW
    Am J Med; 2000 Aug; 109(2):166-8. PubMed ID: 10967161
    [No Abstract]   [Full Text] [Related]  

  • 19. The US Food and Drug Administration's Sentinel Initiative: expanding the horizons of medical product safety.
    Robb MA; Racoosin JA; Sherman RE; Gross TP; Ball R; Reichman ME; Midthun K; Woodcock J
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():9-11. PubMed ID: 22262587
    [No Abstract]   [Full Text] [Related]  

  • 20. National adverse drug reaction surveillance: 1985.
    Faich GA; Knapp D; Dreis M; Turner W
    JAMA; 1987 Apr; 257(15):2068-70. PubMed ID: 3560382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.